Dr Lyronne Olivier Breast cancer is one of the most common cancers diagnosed in women, yet it remains surrounded by many myths and misconceptions...
Vous n'êtes pas connecté
Optiscan Imaging has received the nod of approval to start taking in-human images during surgery for breast cancer patients using its “InVue” technology.
Dr Lyronne Olivier Breast cancer is one of the most common cancers diagnosed in women, yet it remains surrounded by many myths and misconceptions...
Bavina Sookdeo Breast reconstruction is more than a medical procedure – it is, says breast oncologist and reconstructive surgeon Dr Rajen...
Bavina Sookdeo Breast reconstruction is more than a medical procedure – it is, says breast oncologist and reconstructive surgeon Dr Rajen...
A century ago, a breast cancer diagnosis came with a grim prognosis. The five-year survival rate for breast cancer in the U.S. during the 1920s was...
A century ago, a breast cancer diagnosis came with a grim prognosis. The five-year survival rate for breast cancer in the U.S. during the 1920s was...
Bavina Sookdeo When most people hear the words “breast cancer,” they think of women. But clinical oncologist Dr Nazreen Bhim issues a...
Bavina Sookdeo When most people hear the words “breast cancer,” they think of women. But clinical oncologist Dr Nazreen Bhim issues a...
REGN secures FDA approval to expand Libtayo's label for high-risk skin cancer, boosting its oncology momentum amid Eylea sales pressure.
AstraZeneca Pharma has secured approval from India's drug...
AstraZeneca Pharma has secured approval from India's drug...